Article
C5a receptor signalling in dendritic cells controls the development of maladaptive Th2 and Th17 immunity in experimental allergic asthma.
Mucosal immunology - 1 Jul 2013
Schmudde I, Ströver H A, Vollbrandt T, König P, Karsten C M, Laumonnier Y, Köhl J
Abstract excerpt
The pathways underlying dendritic cell (DC) activation in allergic asthma are incompletely understood. Here we demonstrate that adoptive transfer of ovalbumin-pulsed wild-type (wt) but not of C5a receptor-deficient (C5aR⁻/⁻) bone marrow (BM)-derived DCs (BMDCs) induced mixed T helper type 2 (Th2)/Th17 maladaptive immunity, associated with severe airway hyperresponsiveness, mucus production, and mixed...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
